Q , A, F, X, W, Z, Z, R*, W*. Enhancing PPARγ by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice. Pharmacol Res. 2020;160:105059. 1, 1, , , , , , . New activators of eIF2α Kinase Heme-Regulated Inhibitor (HRI) with improved biophysical properties. 2020;187:111973. Cao Y, Ding W, Zhang J, Gao Q, Yang H, Cao W, Wang Z*, Fang L*, Du R*. J Proteome Res. 2019;18(5):2032-2044. Qin T1, Du R1, Huang F, Yin S, Yang J, Qin S, Cao W. Free Radical Bio Med. 2016;92:90-99. Qin S1, Du R1, Yin S, Liu X, Xu G, Cao W. Inflamm Res. 2015;64(7):537-548. , , , , , , , . Fumigaclavine C activates PPARγ pathway and attenuates atherogenesis in ApoE-deficient mice. 2014;234(1):120-128 Jeong Y1, Du R1, Zhu X, Yin S, Wang J, Cui H, Cao W, Lowenstein CJ. J Leukoc Biol. 2014;95(4):651-659
|